Research Scientist (BS/MS), Cell and Molecular Biology, MSD
1. That's the number of current viral gene therapy treatments approved by the FDA and EMA for any neuromuscular disease. Novartis' AAV gene therapy approved for the treatment of spinal muscular atrophy offers patients a transformative option in their fight with this devastating disease. Novartis Institutes for Biomedical Research and the Musculoskeletal disease area are committed to development of the next generation of life saving medicines for the world's most severe medical disorders. We are seeking a talented and self-motivated scientist to join our preclinical stage research group in Cambridge, MA. As part of a team, the successful candidate will design and conduct in vitro and cellular studies in support of the discovery and characterization of therapeutics (low mol
This job listing is no longer active.
Check the left side of the screen for similar opportunities.